MHLW Ups Ante for Regulatory Reviews of Jointly Developed Generics

July 7, 2021
In response to recent GMP issues and fudged drug filing scandals, the Ministry of Health, Labor and Welfare (MHLW) will strengthen regulatory reviews for jointly developed generics and verify their manufacturing and quality control systems during the review process, according...read more